From the official registers: KBO 12 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
DF PHARMA SERVICES is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €217,453 and a net result of €198,853, of which €200,000 non-recurring income. Equity is growing by about 7.7% per year across the filed financial years. Its solvency ranks better than 14% of 6,680 sector peers (NACE 64, financial year 2025). The company has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
14-12
Gazette deed
Resignations: DAENEN Frank (niet statutaire zaakvoerder) and FOULON Petra (niet statutaire zaakvoerder)Appointments: DAENEN Frank (director) and FOULON Petra (director) · Capital conversion · Reserve release15 facts ▸
- General meeting, 28-11-2023
- Other provision, “aanpassing statuten aan WVV en behoud rechtsvorm, behouden” (deed in Dutch)
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Reserve release, “vormen en meerderheden statutenwijziging, opheffing” (deed in Dutch)
- Other provision, “vrijstelling voorlezing verslag bestuursorgaan over voorwerpwijziging, verslag bestuursorgaan met betrekking tot voorgestelde wijziging voorwerp” (deed in Dutch)
- Purpose change
- Amendment of the articles
- Capital
- Director resignation, DAENEN Frank (niet statutaire zaakvoerder)
- Director appointment, DAENEN Frank (director (not named in the articles))
- Director resignation, FOULON Petra (niet statutaire zaakvoerder)
- Director appointment, FOULON Petra (director (not named in the articles))
- +3 further facts in this act
Sources:Publications in the Belgian Official GazetteFilings with the National Bank